In recent years, hydroxychloroquine has gained attention for its potential role in reducing cardiovascular risk factors such as dyslipidemia and insulin resistance.
plaquenil for lupus Studies have suggested that it may improve lipid profiles, glucose metabolism, and endothelial function in patients with systemic lupus erythematosus or rheumatoid arthritis. While further research is needed to confirm these findings and elucidate the underlying mechanisms, these cardiovascular benefits represent additional potential advantages of hydroxychloroquine therapy.